Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Ramipril
- Therapeutic area
- Cardiovascular
- Drug class
- Antihypertensive medicines
- ATC
- C09AA
- Strength
- 1.25 mg
- Dosage form
- Tablet
- Pack
- 14x2's
- Registration no.
- 057269
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Shaigan Pharmaceuticals (Pvt) Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Remet-1.25 (Ramipril) is used for
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Ramipril is right for you and the dose.
- Chronic kidney disease: first choice for high blood pressure or protein in the urine
- Coronary artery disease (angina): protect the heart and blood vessels
- Heart failure: core medicine for reduced ejection fraction
- High blood pressure (hypertension): a first-choice medicine
- Stroke: long-term control of blood pressure to prevent another stroke, with the target set by your doctor
About Remet-1.25 1.25 mg tablet
Remet-1.25 1.25 mg tablet contains Ramipril 1.25 mg. It is registered with DRAP by Shaigan Pharmaceuticals (Pvt) Ltd (registration no. 057269). Its official price is PKR 493.18 for a pack of 14x2's, about PKR 17.61 per tablet. The price changed from PKR 469.97 to PKR 493.18 on 18 August 2026. 1 other brand of Ramipril 1.25 mg (tablet) is registered in Pakistan. Compare all brands and prices →
All 1 other brands of Ramipril 1.25 mg tablet in Pakistan
These 1 brands are alternatives (substitutes) to Remet-1.25: each contains Ramipril 1.25 mg tablet. Ask your doctor or pharmacist before you switch brands.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Ramipace | PHARMEVO (PVT) LTD | 2x 14's | PKR 429.94 | PKR 15.36 / tablet |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Remet-1.25, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Shaigan Pharmaceuticals (Pvt) Ltd, Rawalpindi
- DRAP registration
- 057269
- Phone
- +92 51 5133060-8
- info@shaigan.com
- Website
- https://shaigan.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
PKR 469.97 to 493.18 (+4.9%) between 24 Sep 2025 and 18 Aug 2026 · 2 official price records · pack 14x2's
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Remet-1.25 1.25 mg, 14x2's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/remet-1-25-1-25-mg-057269-14x2s-shaigan-pharmaceuticals-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 493.18 | 2026-08-18 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 469.97 | 2025-09-24 | 2026-08-08 | DRAP PharmaPrice Index | Historical |
Cite this record
Medicine record · DRAP registration 057269Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.